Surface Oncology, Inc.

SURF · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$64-$78$59-$55
Dep. & Amort.$1$2$2$2
Deferred Tax$0$1-$0-$1
Stock-Based Comp.$7$9$8$6
Change in WC-$8$2-$42-$14
Other Non-Cash$3$3$4$2
Operating Cash Flow-$60-$62$30-$60
Investing Activities
PP&E Inv.-$0-$0-$0-$2
Net Acquisitions$0$0$0-$17
Inv. Purchases-$40-$112-$1-$118
Inv. Sales/Matur.$63$13$59$137
Other Inv. Act.$0$0$0$17
Investing Cash Flow$23-$99$58$17
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$31$30$29$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$32$43$40$7
Financing Cash Flow$32$43$40$7
Forex Effect$0$0$0$0
Net Chg. in Cash-$5-$119$128-$36
Supplemental Information
Beg. Cash$58$177$48$84
End Cash$53$58$177$48
Free Cash Flow-$60-$62$30-$62